￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
When will Rubicatin (Rubitidine) be launched in the country? Drug launch progress and patient purchase

2026-02-01 22:25:32

Check Details
What are the common manifestations of resistance to Pralsetinib?

2026-02-01 22:25:32

Check Details
Analysis of the mechanism of action of capmatinib targeted drug

2026-02-01 22:25:32

Check Details
How much does the Indian version of Sotorasib cost?

2026-02-01 22:25:32

Check Details
New breakthrough in non-muscle invasive bladder cancer: Japanese clinical results of gene therapy ADSTILADRIN announced

2026-02-01 22:25:32

Check Details
TPST-1495 receives FDA orphan drug designation for the treatment of FAP hereditary intestinal polyposis syndrome

2026-02-01 22:25:32

Check Details
How effective is Roflumilast-DALIRESP Hong Kong version?

2026-02-01 22:25:32

Check Details
What is the general market price of a box of ruxolitinib tablets/ruxolitinib in 2025?

2026-02-01 22:25:32

Check Details
What is the correct usage and dosage of clofazimine?

2026-02-01 22:25:32

Check Details
Gosatolizumab/Todavir shows modest activity against CNS metastases

2026-02-01 22:25:32

Check Details
Regarding future directions in evaluating evantumumab in colorectal cancer CRC

2026-02-01 22:25:32

Check Details
Data on medroxyprogesterone and enzalutamide/enzalutamide in castration-resistant prostate cancer

2026-02-01 22:25:32

Check Details
Category
相关知识